WELL HEALTH TECHNOLOGIES COR (WELL.CA) Forecast, Price Target & Analyst Ratings

TSX:WELL • CA94947L1022

Current stock price

4.32 CAD
+0.11 (+2.61%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for WELL HEALTH TECHNOLOGIES COR (WELL.CA).

Forecast Snapshot

Consensus Price Target

Price Target
CA$7.21
+ 66.88% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 13, 2026
Period
Q1 / 2026
EPS Estimate
CA$0.06
Revenue Estimate
377.67M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
CA$7.21
Upside
+ 66.88%
From current price of CA$4.32 to mean target of CA$7.21, Based on 20 analyst forecasts
Low
CA$5.05
Median
CA$7.14
High
CA$9.45

Price Target Revisions

1 Month
-7.38%
3 Months
-7.61%

Price Target Summary

20 Wall Street analysts provided a forecast for the next 12 months for WELL.CA. The average price target is 7.21 CAD. This implies a price increase of 66.88% is expected in the next year compared to the current price of 4.32.
The average price target has been revised downward by 7.61% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

WELL Current Analyst RatingWELL Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10 15

Analyst Ratings History

WELL Historical Analyst RatingsWELL Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Analyst Ratings Consensus

ChartMill Buy Consensus
82.00%
WELL.CA was analyzed by 20 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about WELL.CA.
In the previous month the buy percentage consensus was at a similar level.
WELL.CA was analyzed by 20 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-01-27STIFEL CANADAMaintains Buy -> Buy
2025-12-12PARADIGM CAPITALMaintains Buy -> Buy
2022-11-14Scotiabank CapitalUpgrade Outperform
2022-11-11TD ResearchDowngrade Buy
2022-11-11CIBC Capital MarketsDowngrade Outperform
2022-11-03Scotiabank CapitalDowngrade Outperform
2022-11-03STA ResearchMaintains Buy
2022-10-18Scotiabank CapitalMaintains Outperform
2022-10-14STA ResearchMaintains Buy
2022-10-14Maxim GroupMaintains Buy
2022-10-12CIBC Capital MarketsDowngrade Outperform
2022-09-23STA ResearchReiterate Buy
2022-09-15STA ResearchMaintains Buy
2022-09-15Eight CapitalDowngrade Buy
2022-08-12TD ResearchUpgrade Buy
2022-08-12Scotiabank CapitalMaintains Outperform
2022-08-11CIBC Capital MarketsMaintains Outperform
2022-08-11STA ResearchMaintains Buy
2022-07-22Scotiabank CapitalMaintains Outperform
2022-07-22STA ResearchDowngrade Buy
2022-06-22CIBC Capital MarketsMaintains Outperform
2022-06-22Scotiabank CapitalMaintains Outperform
2022-06-22STA ResearchMaintains Buy
2022-05-20Canaccord CapitalDowngrade Buy
2022-05-20TD ResearchDowngrade Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 13, 2026
Period
Q1 / 2026
EPS Estimate
CA$0.06
Revenue Estimate
377.67M
Revenue Q2Q
28.40%
EPS Q2Q
130.20%
Number of Analysts
11

Next Earnings Revisions

Revenue (1 Month)
-0.40%
Revenue (3 Months)
-1.05%
EPS (1 Month)
-8.16%
EPS (3 Months)
-27.42%

Next Earnings Summary

WELL.CA is expected to report earnings on 5/13/2026. The consensus EPS estimate for the next earnings is 0.06 CAD and the consensus revenue estimate is 377.67M CAD.
The next earnings revenue estimate has been revised downward by 1.05% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2028

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
WELL.CA revenue by date.WELL.CA revenue by date.
776.054M
36.37%		919.688M
18.51%		1.4B
52.25%		1.596B
13.99%		1.704B
6.77%		1.807B
6.04%
EBITDA
YoY % growth
WELL.CA ebitda by date.WELL.CA ebitda by date.
95.289M
20.31%		41.541M
-56.41%		186.467M
348.87%		186.33M
-0.07%		205.93M
10.52%		239.75M
16.42%
EBIT
YoY % growth
WELL.CA ebit by date.WELL.CA ebit by date.
34.521M
43.84%		-30.765M
-189.12%		92.705M
401.33%		85.159M
-8.14%		103.56M
21.61%		104.58M
0.98%
Operating Margin
WELL.CA operating margin by date.WELL.CA operating margin by date.
4.45%-3.35%6.62%5.34%6.08%5.79%
EPS
YoY % growth
WELL.CA eps by date.WELL.CA eps by date.
-0.18
-2,594,073,385,365,405,700.00%		0.15
183.33%		0.11
-26.67%		0.30
172.00%		0.40
32.58%		0.31
-22.86%

All data in CAD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		0.06
130.20%		0.06
61.49%		0.07
13.34%		0.08
-60.90%		0.06
-2.22%		0.06
-5.26%		0.07
-2.50%		0.07
-15.22%
Revenue
Q2Q % growth		377.67M
28.40%		397.23M
11.37%		402.62M
10.43%		419.42M
9.01%		413.41M
9.46%		427.34M
7.58%		431.03M
7.06%		443.68M
5.78%
EBITDA
Q2Q % growth		42.239M
54.87%		45.868M
-35.44%		45.273M
-55.09%		49.067M
-60.20%		46.663M
10.47%		48.719M
6.22%		50.258M
11.01%		53.354M
8.74%
EBIT
Q2Q % growth		13.436M
73.88%		17.117M
-34.43%		12.687M
-56.76%		16.802M
-43.11%		10.04M
-25.28%		12.497M
-26.99%		13.421M
5.79%		14.401M
-14.29%

All data in CAD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

WELL.CA Yearly Revenue VS EstimatesWELL.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
WELL.CA Yearly EPS VS EstimatesWELL.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 0.4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
40.64%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
8.14%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
39.56%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

WELL HEALTH TECHNOLOGIES COR / WELL.CA Forecast FAQ

What is the average price target for WELL HEALTH TECHNOLOGIES COR (WELL.CA) stock?

20 analysts have analysed WELL.CA and the average price target is 7.21 CAD. This implies a price increase of 66.88% is expected in the next year compared to the current price of 4.32.

Can you provide the upcoming earnings date for WELL HEALTH TECHNOLOGIES COR?

WELL HEALTH TECHNOLOGIES COR (WELL.CA) will report earnings on 2026-05-13.

What are the consensus estimates for WELL HEALTH TECHNOLOGIES COR (WELL.CA) next earnings?

The consensus EPS estimate for the next earnings of WELL HEALTH TECHNOLOGIES COR (WELL.CA) is 0.06 CAD and the consensus revenue estimate is 377.67M CAD.

Can you provide the consensus rating for WELL HEALTH TECHNOLOGIES COR stock?

The consensus rating for WELL HEALTH TECHNOLOGIES COR (WELL.CA) is 82 / 100 . This indicates that analysts generally have a positive outlook on the stock.